Bionano Genomics Inc (NASDAQ: BNGO) is -75.98% lower on its value in year-to-date trading and has touched a low of $0.31 and a high of $3.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNGO stock was last observed hovering at around $0.48 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.45, the stock is -7.42% and -15.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing -5.40% at the moment leaves the stock -55.15% off its SMA200. BNGO registered -87.21% loss for a year compared to 6-month loss of -57.96%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 5.98% gain in the last 1 month and extending the period to 3 months gives it a -45.64%, and is -0.44% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.83% over the week and 9.53% over the month.
Bionano Genomics Inc (BNGO) has around 344 employees, a market worth around $31.38M and $36.58M in sales. Profit margin for the company is -557.98%. Distance from 52-week low is 48.61% and -88.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-236.94%).
Bionano Genomics Inc quarterly earnings per share for the current quarter are estimated at -0.22 with sales reaching $8.21M over the same period.The EPS is expected to grow by 82.81% this year, but quarterly earnings will post 1.10% year-over-year.
70.0 institutions hold shares in Bionano Genomics Inc (BNGO), with institutional investors hold 11.78% of the company’s shares. The shares outstanding are 69.11M, and float is at 68.75M with Short Float at 5.35%. Institutions hold 11.76% of the Float.
